CLINICAL_TRIALS
trial_result
· 2021-08-26
Clinical Trial Update: Tryptophan MRI in People With Schizophrenia and Healthy Controls [Phase 2, Phase 3]
Summary
Phase 2/3 clinical trial evaluating tryptophan MRI in people with schizophrenia and healthy controls has completed, with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-08-26